Ben Herrick, MBA
About Ben Herrick, MBA
Ben Herrick, MBA, serves as the Finance Director for East/West Coast Cell Therapy Manufacturing at Kite Pharma. He has extensive experience in finance across various companies, including Chemtool, Astellas Pharma, and AbbVie, and holds an MBA from the University of Maryland.
Current Role at Kite Pharma
Ben Herrick serves as the Finance Director for East/West Coast Cell Therapy Manufacturing at Kite Pharma. He has held this position since 2021, working from the company's location in El Segundo, California. In this role, he oversees financial operations and strategies for cell therapy manufacturing across both coasts.
Previous Experience at Kite Pharma
Prior to his current role, Ben Herrick worked as the Associate Finance Director for West Coast Cell Therapy Manufacturing at Kite Pharma from 2020 to 2021. During his tenure, he implemented finance transformation initiatives aimed at enhancing financial planning and business analysis processes within the organization.
Education and Expertise
Ben Herrick holds a Master of Business Administration (MBA) with a focus on Accounting from the University of Maryland. He also earned a Bachelor of Science in Finance from DePaul University. His expertise includes change management, particularly in the context of new systems implementation in the finance sector.
Career Background in Finance
Ben Herrick has extensive experience in finance, having worked in various roles across multiple organizations. His career includes positions at Astellas Pharma US, where he served as Finance Clinical Oncology Development, and at AbbVie, where he held several roles including Sr. FP&A Manager and Finance Project Manager in Asia Pacific. He also worked at Abbott, EMD, and Lockheed Martin in financial analyst capacities.
Achievements in Project Management
Throughout his career, Ben Herrick has developed a strong background in project management within the finance industry. He has contributed to successful project completions, particularly during his time at AbbVie, where he managed finance projects in the Asia Pacific region.